Center for High-Throughput Minimally-Invasive Radiation Biodosimetry

描述（由申请人提供）：这个整体CMCR计划代表了一个高度集中的目标的多学科方法：高通量生物剂量学及其在辐射诱导损伤的个体化早期预测中的应用。哥伦比亚CMCR项目的一个中心特征仍然是关注三种不同的高通量方法：全自动细胞遗传学（项目1）、功能基因组学（项目2）和代谢组学（项目3）。这些不同的方法代表了一系列的风险-效益平衡，追求所有三种方法对每一种方法都有协同效益，不仅在共同的实验设计和样本共享方面，而且在相互比较和解释结果及其实际意义方面。 这三个项目由四个综合科学核心支持，每个项目都有相同的共同主题：1。复杂暴露的高通量生物剂量学：目标是评估不同的暴露方案，特别是不同的剂量率，内部发射体和中子暴露，如何调节生物标志物的反应，以及调查生物标志物，独特地反映了不同的暴露方案的存在。2.走向高通量放射敏感性/晚期损伤的个体化预测：转录组学和代谢组学方法已被证明在预测个体化辐射诱导的急性效应方面具有实用性，这一概念将扩展到晚期效应。项目1的重点是放射治疗患者的肺炎与离体血液照射后高通量DNA损伤终点之间的潜在相关性。项目2和3的重点是转录组学和代谢组学生物标志物，用于小鼠肺致死率的个体化早期预测。为了与个体敏感性的主题保持一致，计划研究炎症性疾病的重要性，以及作为辐射缓解剂开发辅助手段的预测性测定，作为缓解剂有效性的早期指标。3.技术开发：我们的目标是利用商业高通量筛选技术，用于基于细胞的筛选，转录组学和质谱分析，这些技术在大学和工业环境中越来越多。新的分析方案和“前端”样本采集系统将利用这些通用设备。进一步的技术发展是一种廉价的连续降低剂量率的137 Cs辐照器，模拟任何时间减少的剂量率所造成的内部137 Cs曝光，该设备可以提供一个主要的刺激CMCR 137 Cs内部发射研究。 保持高度统一的组织结构。监督最高级别的科学计划是外部科学咨询小组（ESAG），其成员每年亲自会面。内部咨询委员会（IAC）负责整个CMCR计划的本地协调。ESAG和IAC之间的互动对该计划的科学方向至关重要。

DESCRIPTION (provided by applicant): This overall CMCR program represents a cohesive multidisciplinary approach to highly focused goals: High-throughput biodosimetry and its application to individualized early prediction of radiation-induced injury. A central characteristi of the Columbia CMCR program remains a focus on three different high-throughput approaches: fully-automated cytogenetics (Project 1), functional genomics (Project 2), and metabolomics (Project 3). These different approaches represent a range of risk-benefit balances, and pursuing all three is of synergetic benefit to each, not only in terms of common experimental design and sample sharing, but also in terms of intercomparing and interpreting the results and their practical significance. The three Projects, supported by four integrated scientific Cores, each share the same common themes: 1. Towards High-Throughput Biodosimetry for Complex Exposures: The goal is to assess how different exposure scenarios, in particular different dose rates, internal emitters, and neutron exposure, modulate biomarker response, as well as investigating biomarkers that uniquely reflect the presence of different exposure scenarios. 2. Towards High-Throughput Individualized Predictors of Radiosensitivity / Late Injury: Transcriptomics and metabolomics approaches have been shown here to have utility for predicting individualized radiation-induced acute effects, and this concept will be extended toward late effects. The Project 1 focus is on potential correlations between pneumonitis in radiotherapy patients and high-throughput DNA damage endpoints after ex-vivo blood irradiation. The Project 2 and 3 focus is on transcriptomic and metabolomic biomarkers for individualized early prediction of pulmonary lethality in mice. In keeping with the theme of individual sensitivity, studies are planned of the significance of inflammatory diseases, as well as of predictive assays as an adjunct to radiation mitigator development, as early indicators of mitigator effectiveness. 3. Technology Development: The goal is to take advantage of commercial high-throughput screening technologies, for cell-based screening, transcriptomics, and mass spectrometry, which are increasingly available in university and industry settings. New assay protocols and "front-end" sample acquisition systems will take advantage of these common devices. A further technology development is an inexpensive continuously-decreasing-dose-rate 137Cs irradiator, simulating any time-decreasing dose rate caused by internal 137Cs exposure; the device can provide a major stimulus to CMCR 137Cs internal-emitter studies. A highly unified organizational structure will be maintained. Overseeing the scientific program at the highest level is the External Scientific Advisory Group (ESAG), whose members meet in person annually. The Internal Advisory Committee (IAC) has responsibility for local coordination of the entire CMCR Program. The interactions between the ESAG and the IAC have been central to the Program's scientific direction.